pexels-adrien-olichon-1257089-3137078.jpg

Development Leadership across the program lifecycle

Archentis Partners provides integrated leadership across the drug development lifecycle, helping life science organizations translate scientific innovation into structured, execution-ready development programs. Our services span development strategy, program leadership, operational partnerships, and regulatory submission governance.

Development Strategy and Planning

Successful development programs begin with a clearly defined strategy that aligns scientific objectives with regulatory pathways and operational execution. Archentis Partners works with leadership teams to design integrated development strategies and plans that define the most efficient path from early development through regulatory submission. By structuring programs around clear milestones, critical path activities, and strategic decision points, we help organizations make informed choices about program direction, resource allocation, and long-term development investment.

  • A clearly defined Target Product Profile (TPP) is one of the most effective tools for aligning development strategy with regulatory expectations. Programs that fail to incorporate a formal TPP during development planning have historically experienced longer regulatory review timelines and a greater likelihood of refuse-to-file notifications.

    Archentis works with your team to develop the TPP as a strategic, living document that defines a your product’s characteristics from inception to commercialization. Defined TPPs direct and align efforts, allowing teams to make informed decisions throughout the development lifecycle - from early phase to commercial competitive positioning.

  • Archentis guides the development of Integrated Development Plans (IDPs) that connect scientific strategy with the detailed cross-functional activities. Through detailed milestone planning and critical path analysis, we help organizations define clear development pathways and align programs around achievable timelines and strategic objectives.

    Spanning early development through NDA or BLA submission, IDPs provide the foundation for scenario planning, resource allocation, and program budgeting. By modeling the interdependencies between development activities, the IDP enables teams to understand how changes in timing or scope may affect downstream milestones, timelines, and financial commitments—supporting more informed and strategic decision-making at the executive level.

  • Drug development programs require substantial and carefully managed investment over many years. Archentis Partners estimates the capital required to advance programs through key development milestones and ultimately toward regulatory approval. By linking program timelines and development activities to projected costs, we provide leadership teams with clear visibility into funding requirements, enabling informed decisions around capital planning, program prioritization, and development strategy.

Development Program Leadership

Complex drug development programs require disciplined leadership to align strategy, teams, and execution across multiple functions. Archentis provides embedded program leadership to guide cross-functional development efforts, establish effective governance structures, and maintain alignment around critical milestones. By integrating program planning, decision frameworks, and risk management, we help organizations advance development programs with clarity, accountability, and execution discipline.

  • Archentis provides embedded leadership for global development programs, aligning cross-functional teams around integrated strategies, clear milestones, and disciplined execution. By establishing governance frameworks, guiding integrated development planning, and proactively managing risk, we help organizations advance complex assets efficiently through critical clinical and regulatory milestones.

    We work with your team to create a detailed project gantt, run the cross-functional program meetings and implement stage appropriate project management best practices (PMO gap assessment, meeting minutes, action logs, action item follow up, centralized cloud folder structure, etc).

    Effective project leadership maintains visibility and control -ultimately providing a blueprint for consistent execution across multiple phases.

  • Project governance is a strategic framework that defines how decisions are made, who holds responsibility, and communication flows throughout a project’s lifecycle. Archentis designs company specific processes that ensure that key stakeholders are aligned on objectives, risks and mitigations, communication lines, and accountability are clearly established.

    This approach reduces confusion over who approves changes, keeping the project on track to meet both immediate goals and broader organizational priorities. 

  • We implement structured processes to identify program risks, evaluate mitigation strategies, and protect critical development timelines. Our approach combines proactive risk assessment with disciplined milestone tracking to ensure development programs maintain momentum and avoid preventable delays.

    Archentis aims to foster a continuously mindful risk culture with the program teams.

  • We facilitate alignment across executive leadership, program teams, and external partners to ensure development strategy and execution remain synchronized with corporate priorities. Through structured communication and governance forums, we help organizations maintain clarity and focus as programs evolve.

    We tailor the frequency of meetings to the program, set agendas, and escalate the highest priority items; ensuring decision makers are always aware of program status and key decisions.

Development Operations & Alliance Management

Effective drug development increasingly relies on a network of external partners, including contract research organizations, manufacturing partners, academic collaborators, and specialized experts. Archentis Partners helps organizations structure and manage these relationships to ensure that external activities remain tightly aligned with program strategy, development timelines, and regulatory objectives.

We establish governance frameworks, oversee vendor performance, and guide outsourcing strategies that enable organizations to scale development capabilities while maintaining clear accountability and operational discipline across complex partner ecosystems.

  • Archentis Partners provides oversight of external development partners to ensure outsourced activities remain aligned with program objectives, timelines, and quality standards. We work closely with CROs, CDMOs, and specialized vendors to establish clear governance, performance expectations, and communication frameworks. Through disciplined milestone tracking and issue escalation processes, we help organizations maintain visibility and accountability across complex outsourced development activities.

  • Archentis Partners establishes governance frameworks that support productive collaboration with academic institutions, industry partners, and key opinion leaders. By defining roles, decision pathways, and communication structures, we ensure partnerships remain strategically aligned with program goals.

  • Archentis advises organizations on outsourcing models that balance operational efficiency, technical expertise, and development timelines. We help leadership teams determine which activities should be outsourced, identify appropriate partners, and structure engagements to support program execution. By aligning outsourcing decisions with program strategy and development milestones, we enable organizations to scale capabilities while maintaining strong oversight of critical development activities.

Regulatory Submission Governance

Regulatory submissions represent some of the most critical milestones in a development program and require disciplined planning, coordination, and governance across multiple functions. Archentis Partners helps organizations structure regulatory strategies and submission plans that align clinical, nonclinical, CMC, and operational activities around clearly defined regulatory objectives. Through integrated planning, cross-functional coordination, and proactive risk management, we support teams in navigating complex regulatory pathways and preparing high-quality submissions with confidence.

  • We support the development of structured regulatory submission plans that align cross-functional deliverables with submission timelines and regulatory milestones. By coordinating activities across clinical, regulatory, nonclinical, and CMC teams, we help organizations ensure that critical submission components are planned, sequenced, and executed efficiently.

  • Successful regulatory submissions require close collaboration across multiple disciplines. Archentis facilitates cross-functional coordination among clinical, regulatory, nonclinical, and CMC teams to ensure that submission content, timelines, and dependencies remain aligned as programs progress toward key regulatory filings.

  • Preparing for a regulatory submission requires clear oversight of deliverables, timelines, and decision points. Archentis helps organizations establish governance processes that monitor submission readiness, ensure accountability across teams, and support leadership in making informed decisions as regulatory milestones approach.

Investor Advisory & Development Diligence

Archentis Partners supports investors, boards, and strategic partners in evaluating the strength, feasibility, and execution readiness of drug development programs.

We provide structured, independent assessments of development strategy, execution risk, timelines, and capital requirements—helping investors understand the path to key value inflection points and regulatory approval.

Areas of Focus

  • Development strategy and integrated plan assessment

  • Execution risk and operational readiness

  • Timeline and milestone feasibility

  • Capital requirement and funding analysis

Strategy | Leadership | Partnerships

If your organization is preparing to advance a development program or navigate a critical regulatory milestone, we welcome the opportunity to discuss how Archentis Partners can support your team.